GSK8573 |
| Catalog No.GC38049 |
GSK8573 es un compuesto de control inactivo para GSK2801 (inhibidor competitivo de acetil-lisina de los bromodominios BAZ2A y BAZ2B). GSK8573 tiene actividad de uniÓn a BRD9 con un valor Kd de 1,04 μM y es inactivo frente a BAZ2A/B y otra familia de bromodominios. GSK8573 se puede utilizar como compuesto de control negativo estructuralmente relacionado en experimentos biolÓgicos.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1693766-04-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
GSK8573 (compound 23) is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 with a Kd value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain familiy[1].
[1]. Chen P, et al. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B. J Med Chem. 2016 Feb 25;59(4):1410-24.
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *